Minerals Technologies declares quarterly dividend of $0.13
Minerals Technologies Inc. announces a quarterly dividend of $0.13 per share, payable on December 3, 2026, to shareholders of record on November 5, 2026.
Medline Inc. to Discontinue All Medline Brand Beds
Medline Inc. announces a voluntary field action to remove all Medline Brand beds, affecting $60 million in sales and incurring up to $220 million in costs.
Allspring Global Dividend Opportunity Fund Changes Fiscal Year End
Allspring Global Dividend Opportunity Fund shifts its fiscal year end to December 31, aligning with calendar year-end practices for better reporting.
Plumas Bancorp Declares Quarterly Cash Dividend of $0.33
Plumas Bancorp announces a quarterly cash dividend of $0.33 per share, payable on November 17, 2026, reflecting its commitment to shareholder value.
Korro Bio announces preclinical results for KRRO-111
Korro Bio, Inc. reveals preclinical results for KRRO-111, a treatment for Alpha-1 Antitrypsin Deficiency, potentially impacting the pharmaceutical industry.
Structured Obligations Corp announces distribution to holders
Structured Obligations Corp Long Term Certs Series 2003-5 reports a distribution to certificate holders, highlighting ongoing activity in asset-backed securities.
Structured Obligations Corp announces distribution for 2026
Structured Obligations Corp Long Term Certs Series 2003-4 announces a distribution to holders of its Select Notes Trust LT 2003-4, totaling $168,696.63.
Biohaven receives FDA nod for Vyglxia resubmission review
Biohaven Ltd. announces FDA acceptance of its resubmission for Vyglxia, a drug for spinocerebellar ataxia, marking a crucial step in its development.
Structured Obligations Corp Announces Distribution to Holders
Structured Obligations Corp Select Notes Trust LT Series 2003-1 announces a distribution to certificate holders, reflecting ongoing activity in asset-backed securities.
MBX Biosciences appoints Peter Radovich as new director
MBX Biosciences has appointed Peter Radovich to its board of directors, signaling a strategic move in the pharmaceutical preparations sector.
Fractyl Health announces workforce reduction, leadership change
Fractyl Health, Inc. announces a 45% workforce reduction and the retirement of its President, Jay Caplan, as part of a strategic shift.
MIRA Pharmaceuticals Reports Positive Results for MIRA-55
MIRA Pharmaceuticals announces promising results from a preclinical study of MIRA-55, a potential pain relief drug, aiming for an IND submission in 2027.
Kearny Financial holds Annual Meeting; key votes reported
Kearny Financial Corp. reports results from its Annual Meeting, including director elections and auditor appointments, impacting shareholder engagement.
Plumas Bancorp unveils new investor presentation
Plumas Bancorp has announced a new investor presentation, highlighting its commitment to transparency and engagement with stakeholders.
Nevada Canyon Gold Corp. updates on Lapon Canyon Project
Nevada Canyon Gold Corp. shares insights on the Lapon Canyon Project following recent drill results, impacting the gold and silver ores sector.
Aptera Motors extends Interim CFO Tom DaPolito's contract
Aptera Motors Corp has extended the contract of Interim CFO Tom DaPolito through 2027, signaling a commitment to stable financial leadership.
Tempest Therapeutics holds special meeting, adjourns for vote
Tempest Therapeutics' special meeting to amend voting requirements adjourns without approval, with a follow-up meeting scheduled for November 12, 2026.
Worthington Steel Issues Statement Ahead of Kloeckner EGM
Worthington Steel addresses Kloeckner & Co's upcoming extraordinary general meeting, detailing the potential impact of a key vote.
Roivant Sciences reports positive Phase 3 results for brepocitinib
Roivant Sciences announces positive Phase 3 results for brepocitinib, a potential treatment for non-infectious uveitis, signaling a breakthrough in the pharmaceutical industry.
Genprex highlights TUSC2 gene findings in new research release
Genprex, Inc. reveals new research on TUSC2 gene's role in brain aging, potentially impacting cancer therapies and neurodegenerative disease understanding.